Cure My Disease

Don't miss your cure!

 Log in / Sign up

Healthy volunteers needed to create early warning system for disease

NCT ID NCT07569094

Knowledge-focused Sponsor: Zhonghao Fang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to collect blood and sputum samples from 300 healthy adults aged 18-65 to create a comprehensive database of normal health markers. By analyzing genetics, proteins, and other molecules, researchers hope to better understand what 'healthy' looks like and improve early disease detection. Participants must have no chronic diseases or recent infections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

healthy populations

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age: 18 - 65 years old, gender not restricted; 2. No clear history of chronic diseases (hypertension, diabetes, cardiovascular and cerebrovascular diseases, chronic liver and kidney diseases, tumors, etc.); 3. No infection history in the past 3 months (fever, cough, sore throat, etc.); 4. No use of antibiotics, hormones, immunosuppressants, etc. within the past 1 month; 5. Voluntarily sign the informed consent form and cooperate to complete the follow-up. Exclusion Criteria: 1. Abnormal laboratory indicators (ALT/AST \> 2 times the upper limit of normal value, Cr \> upper limit of normal value, main indicators of blood routine test are abnormal and have clinical significance); 2. Pregnant or lactating women; 3. Recent (within 3 months) history of surgery, trauma or blood transfusion; 4. Mental illness or cognitive impairment that makes it impossible to cooperate with the research.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fifth Affiliated Hospital of Guangzhou Medical University

    Guangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.